UK biotechnology company Touchlight, which is specializing in cell-free DNA manufacturing, has entered into a strategic ...

The US Centers for Medicare & Medicaid Services (CMS) is preparing states for an upcoming change that will limit the ability ...

US biotech Sidewinder Therapeutics has secured $137 million in an oversubscribed series B financing to advance its bispecific ...

Stephen Ubl will step down as president and chief executive of the Research and Manufacturers of America (PhRMA) at the end ...

US pharma major AbbVie (NYSE: ABBV) has filed a lawsuit seeking to narrow the definition of a “340B patient,” opening a new ...

The ALS Association has backed the reintroduction of US legislation aimed at extending programs designed to accelerate ...

US specialty pharma company Cosette Pharmaceuticals announced the closing of a definitive agreement to acquire the US sales ...

Japanese pharma major Daiichi Sankyo (TYO: 4568) has entered a collaboration with Shanghai-based ATLATL Innovation Center to ...

Canada-based biotech Zymeworks today announced the full-time appointments of Dr Adam Schayowitz and Scott Platshon as of ...

Jeito Capital, a Paris, France -based independent private equity fund dedicated to Biopharma, has announced the final closing ...

Illinois, USA-based Assertio Holdings yesterday announced a definitive agreement to be acquired by Garda Therapeutics for $18 ...

Late last year, Julie Dehaene-Puype stepped into the role of Regional President at Kyowa Kirin International (KKI), a ...